Overview
Printcare supplies specialist printing, packaging and digital-media products to more than 350 customers, with export markets and operations extending to Kenya and India. The latest quarter showed an operational recovery from the prior-year loss, but finance costs and other charges still left the group loss-making.
A rights issue became effective on 17 November 2026. It brings new capital for investment and working capital, but shareholders who did not participate face dilution.
Price performance
At LKR 36.00 on 17 November 2026, the share had fallen 12.2% over three months while the ASPI gained 1.0%; over one year it fell 38.4% against a 7.7% ASPI decline. The operating-margin improvement and the three-month price fall therefore point in opposite directions, without proving why the share moved.
The price stood 13.5% of the way through its 52-week range, 43.3% below its high. Recent volatility was 58.8%, above its own one-year norm, while 20-day volume was 45.8% below the preceding 60-day level, indicating quieter trading despite larger price swings.
The three-year record shows two falls of 15% or more, the deepest 53%, which has not yet recovered. Median daily turnover was only LKR 86,286: a LKR 1 million order is more than everything that trades on a typical day (1159% of it), making that size a large part of normal daily trading.
Valuation
The P/E is unavailable because Printcare made a loss over the twelve months to September 2026. Its negative 15.9% return on equity explains why a book-based valuation is more informative than earnings multiples at present.
At 0.55 times P/B, a buyer pays 55 cents for each rupee of net assets, and the stock is the cheapest manufacturing peer on that measure. It is also cheaper than 90% of days since February 2012, so the current discount is unusual in Printcare's own trading record. The market-wide valuation band is fairly valued, with a score of 49 out of 100, because the book-value discount is offset by losses and no earnings or dividend support.
There is no current dividend yield, and no dividend is on record in the last two years. The payout history had already declined from LKR 8.00 per share in FY2022 to LKR 5.50 in FY2023 and LKR 2.00 in FY2024, so the historical income record does not offset the current absence of a payout.
News and sentiment
Direct coverage was normal, with four material articles over the past 90 days and all assessed as neutral. Coverage focused entirely on the rights issue rather than on trading performance or contracts.
The confirmed rights issue became ex-rights on 17 November 2026, offering shares at LKR 30 under a 19:70 ratio. The issue was reported to raise about LKR 700 million for investment and working capital; the offer price was 15.0% below the pre-ex market price, so participating holders contributed fresh cash while non-participants were diluted.
Financials
September-quarter revenue rose 30.4% year-on-year. Gross margin fell from 15.6% to 14.3%, operating margin improved from -2.2% to 1.7%, and net margin improved from -6.9% to -3.1%. The group therefore returned to a small operating profit but still lost about 3 cents on each rupee of sales after finance costs, tax and other charges.
The gross margin was the worst of eight September quarters on record, whereas operating and net margins ranked middling against comparable September quarters. Operating profit improved by LKR 149.5 million year-on-year and the net loss narrowed by LKR 94.6 million, but the LKR 209.9 million below-the-line drag was larger than a year earlier and consumed the operating gain.
Owners' equity was about LKR 0.8 billion lower than a year earlier. The September filing used roughly 86 million shares, matching the count currently shown in issue; the fresh rights issue is therefore not reflected in that filing's per-share figures. Minority shareholders accounted for 32.6% of the annual group loss, meaning group profit and the amount attributable to the ordinary shares are materially different.
Risks
The largest risk is leverage. At March 2026, total debt was LKR 11.5 billion and gearing, meaning debt against owners' equity, was 204.7%, up from 121.3% a year earlier. Operating profit did not cover interest costs, with interest cover at -0.79 times, leaving the balance sheet exposed while profitability remains weak.
Liquidity is tighter than a year earlier. The current ratio, which compares assets expected to turn into cash within a year, including inventories and customer receivables, with bills due within that year, fell from 1.34 to 1.18 times. Free cash flow was negative LKR 1.5 billion, although operating cash conversion of 1.27 times shows the annual operating loss was more than matched by operating cash flow.
The rights issue adds working-capital funding, but it does not itself demonstrate that the group can restore a profit after finance costs. Manufacturing activity expanded in October according to the sector backdrop, but that is sector context rather than evidence of a Printcare-specific recovery.
Outlook
As at 17 November 2026, the next material event is the December 2026 interim filing, expected between 6 and 14 February 2027. It will show whether the September operating recovery continued and whether finance costs still prevent that recovery from reaching ordinary shareholders.
The data cannot yet show how the rights proceeds will translate into earnings. The filing will also provide the first financial update after the rights issue took effect, making its treatment of working capital, debt and the enlarged equity base central to the next assessment.